Issue #246
- Saquinavir: Combination Shows Survival Benefit; New Formulation Trial Recruiting
- Improved HIV Survival Indicates Effect of Therapy
- Kaposi's Sarcoma: DaunoXome« Approved
- Crixivan« Price: Behind the Reduction
- California: 3TC Now Available through ADAP
- Women and HIV: Conference Calls May 14, 15, on Treatment Concerns
- Alternative Treatments for HIV: Nationwide Survey Seeks Users
- Federal Policy: Ryan White, OAR, Testing Newborns
- AIDSWatch 1996: National Lobbying Days in Washington, May 19-21
- Paris Conference on NAC, Similar Therapeutic Approaches, May 21-23
- Vancouver Conference Satellite Meetings, Part II
source: AIDS Treatment News
